Lipocine Q1 EPS $0.66 Up From $(0.76) YoY, Sales $7.50M Up From $54.99K YoY
Lipocine Q1 EPS $0.66 Up From $(0.76) YoY, Sales $7.50M Up From $54.99K YoY
Lipocine第一季度每股收益從同比增長0.76美元（0.76美元）上漲0.66美元，同比增長750萬美元
Lipocine (NASDAQ:LPCN) reported quarterly earnings of $0.66 per share. This is a 186.84 percent increase over losses of $(0.76) per share from the same period last year. The company reported $7.50 million in sales this quarter. This is a 13.54K percent increase over sales of $54.99 thousand the same period last year.
Lipocine（納斯達克股票代碼：LPCN）公佈的季度收益爲每股0.66美元。這比去年同期每股虧損0.76美元（0.76美元）增長了186.84％。該公司報告本季度銷售額爲750萬美元。這比去年同期的54,990美元的銷售額增長了13.54萬個百分點。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。